{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:07:46Z","timestamp":1765728466661},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.2478\/v10039-012-0017-7","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T22:49:35Z","timestamp":1335566975000},"page":"65-70","source":"Crossref","is-referenced-by-count":17,"title":["Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients"],"prefix":"10.1016","volume":"57","author":[{"given":"M","family":"Kosmalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Drozdowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sliwinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Drzewoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.2478\/v10039-012-0017-7_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/dc11-S011","article-title":"Standards for medical care in diabetes","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care."},{"issue":"1","key":"10.2478\/v10039-012-0017-7_bib2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2337\/diacare.27.7.1791","article-title":"The phantom of lactic acidosis due to metformin in patients with diabetes","volume":"27","author":"Misbin","year":"2004","journal-title":"Diabetes Care."},{"issue":"4","key":"10.2478\/v10039-012-0017-7_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archinte.162.4.434","article-title":"Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy","volume":"162","author":"Calabrese","year":"2002","journal-title":"Arch Intern Med."},{"issue":"6","key":"10.2478\/v10039-012-0017-7_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1464-5491.2001.00509.x","article-title":"Contraindications to metformin therapy in patients with type 2 diabetes \u2013 a population based study of adherence to prescribing guidelines","volume":"18","author":"Emslie-Smith","year":"2001","journal-title":"Diabet Med."},{"issue":"6","key":"10.2478\/v10039-012-0017-7_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11096-007-9095-1","article-title":"Contraindications to metformin therapy among patients with type 2 diabetes mellitus","volume":"29","author":"Sweileh","year":"2007","journal-title":"Pharm World Sci."},{"issue":"4","key":"10.2478\/v10039-012-0017-7_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11096-009-9303-2","article-title":"Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome","volume":"31","author":"Pongwecharak","year":"2009","journal-title":"Pharm World Sci."},{"issue":"4","key":"10.2478\/v10039-012-0017-7_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2337\/diacare.28.4.922","article-title":"GOAL A1C Study Team. Renal status among patients using metformin in a primary care setting","volume":"28","author":"Kennedy","year":"2005","journal-title":"Diabetes Care."},{"issue":"1016","key":"10.2478\/v10039-012-0017-7_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/hrt.2009.173773","article-title":"Metformin: safety in cardiac patients","volume":"86","author":"Khurana","year":"2010","journal-title":"Postgrad Med J."},{"issue":"7379","key":"10.2478\/v10039-012-0017-7_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bmj.326.7379.4","article-title":"Contraindications to the use of metformin","volume":"326","author":"Jones","year":"2003","journal-title":"BMJ."},{"issue":"7","key":"10.2478\/v10039-012-0017-7_bib10","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/ndt\/gfn152","article-title":"Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice","volume":"23","author":"Almirall","year":"2008","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"10.2478\/v10039-012-0017-7_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes Care."},{"issue":"3","key":"10.2478\/v10039-012-0017-7_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.28.3.539","article-title":"Comparative outcomes study of metformin intervention versus conventional approach: the COSMIC approach study","volume":"28","author":"Cryer","year":"2005","journal-title":"Diabetes Care."},{"issue":"10","key":"10.2478\/v10039-012-0017-7_bib13","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2337\/diacare.28.10.2585","article-title":"Metformin and heart failure: innocent until proven guilty","volume":"28","author":"Inzucchi","year":"2005","journal-title":"Diabetes Care."},{"issue":"3","key":"10.2478\/v10039-012-0017-7_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardfail.2009.10.022","article-title":"Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes","volume":"16","author":"Shah","year":"2010","journal-title":"J Card Fail."},{"issue":"9","key":"10.2478\/v10039-012-0017-7_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"The Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med."},{"issue":"4","key":"10.2478\/v10039-012-0017-7_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diacare.16.4.621","article-title":"Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups","volume":"16","author":"Nagi","year":"1993","journal-title":"Diabetes Care"},{"issue":"3","key":"10.2478\/v10039-012-0017-7_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1463-1326.2010.01349.x","article-title":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials","volume":"13","author":"Lamanna","year":"2011","journal-title":"Diabetes Obes Metab."},{"issue":"6","key":"10.2478\/v10039-012-0017-7_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dc10-2361","article-title":"Use of metformin in the setting of mild-to-moderate renal insufficiency","volume":"34","author":"Lipska","year":"2011","journal-title":"Diabetes Care."},{"issue":"2","key":"10.2478\/v10039-012-0017-7_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2337\/dc06-2155","article-title":"Is metformin safe in patients with mild renal insufficiency?","volume":"30","author":"Kazory","year":"2007","journal-title":"Diabetes Care."},{"issue":"2 Suppl 1","key":"10.2478\/v10039-012-0017-7_bib20","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis."},{"issue":"Suppl.1","key":"10.2478\/v10039-012-0017-7_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0167-4943(96)86947-0","article-title":"Metformin treatment in elderly type II diabetic patients","volume":"22","author":"Gregorio","year":"1996","journal-title":"Arch Gerontol Geriatr."},{"issue":"5","key":"10.2478\/v10039-012-0017-7_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1503\/cmaj.045292","article-title":"Metformin's contraindications should be contraindicated","volume":"173","author":"McCormack","year":"2005","journal-title":"CMAJ."},{"issue":"12","key":"10.2478\/v10039-012-0017-7_bib23","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s00125-005-0026-1","article-title":"Contraindications can damage your health-is metformin a case in point?","volume":"48","author":"Holstein","year":"2005","journal-title":"Diabetologia."},{"issue":"4","key":"10.2478\/v10039-012-0017-7_bib24","doi-asserted-by":"crossref","first-page":"c380","DOI":"10.1159\/000323739","article-title":"Metformin: The safest hypoglycaemic agent in chronic kidney disease?","volume":"118","author":"Nye","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.2478\/v10039-012-0017-7_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00125-011-2351-x","article-title":"Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment","volume":"55","author":"Panossian","year":"2012","journal-title":"Diabetologia"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614601103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614601103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/versita.metapress.com\/index\/78R084881M518063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T15:27:49Z","timestamp":1542986869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112614601103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1896112614601103"],"URL":"https:\/\/doi.org\/10.2478\/v10039-012-0017-7","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}